Brian Oliver

Brian Oliver is a principal development scientist focused on molecular assay development. Before coming to GentiBio, Brian was a Principal Scientist with the Genetic Engineering and Molecular Assay teams at Juno Therapeutics (now BMS), where his team supported methods essentially for the approval of Breyanzi and the development of methods assaying gene-edited cell therapy products.

Brian obtained a BS in Biology from the University of Cincinnati and a Ph.D. in Pathobiology and Molecular Medicine from the University of Cincinnati College of Medicine.